Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare clinical trial coverage

This article was originally published in The Gray Sheet

Executive Summary

National coverage decision addressing routine care costs in clinical trials could be issued by the Health Care Financing Administration as early as the week of July 24. Included will be definitions of what the agency considers "routine" care costs and which clinical trials qualify for such coverage, staffers note. Following a comment period, HCFA intends to make the decision effective by Sept. 15. Implementation would fulfill one part of a June 7 Presidential executive memo which also directs HCFA to explore the possibility of expanding Medicare coverage to certain experimental procedures (1"The Gray Sheet" June 12, p. 5)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel